biospecimen_aliquot__bcr_aliquot_barcode	tcga-a7-a5zx-01a-12d-a29n-09
biospecimen_aliquot__bcr_aliquot_uuid	1e19a22f-97e3-4a9a-aa55-fb18dd6b674b
biospecimen_aliquot__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_aliquot__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0145634404
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2013-05-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a29n
biospecimen_aliquot__plate_row	b
biospecimen_aliquot__quantity	2.80
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a7-a5zx-01a-12d
biospecimen_analyte__bcr_analyte_uuid	35e82400-5701-4b4a-b7b5-8373355f3ddc
biospecimen_analyte__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_analyte__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_analyte__concentration	0.14
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a7-a5zx
biospecimen_diagnostic_slides__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	a4c651f0-db8e-4534-84a2-ad875f62209f
biospecimen_normal_control__bcr_patient_barcode	tcga-a7-a5zx
biospecimen_normal_control__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_portion__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_portion__bcr_portion_barcode	tcga-a7-a5zx-01a-12
biospecimen_portion__bcr_portion_uuid	88cbea17-388a-4f4c-8c30-3c6ea1f9b706
biospecimen_portion__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_portion__date_of_creation	2013-03-19
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	12
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a7-a5zx-01a-12d
biospecimen_protocol__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_protocol__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_sample__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_sample__bcr_sample_uuid	bc4ef13b-1ab7-4929-953d-45592691394f
biospecimen_sample__days_to_collection	76
biospecimen_sample__initial_weight	70
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-a7-a5zx.a8834d03-81f5-43bc-a4ab-f215c89cb095.pdf
biospecimen_sample__pathology_report_uuid	a8834d03-81f5-43bc-a4ab-f215c89cb095
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
biospecimen_slide__bcr_sample_barcode	tcga-a7-a5zx-01a
biospecimen_slide__bcr_slide_barcode	tcga-a7-a5zx-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	34a6187f-702f-49c0-bf87-4c496fb5dd43
biospecimen_slide__image_file_name	tcga-a7-a5zx-01a-01-ts1.34a6187f-702f-49c0-bf87-4c496fb5dd43.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	40
biospecimen_slide__percent_monocyte_infiltration	20
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	20
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	30
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a7-a5zx
biospecimen_tumor_sample__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_drug__bcr_drug_barcode	tcga-a7-a5zx-d51334
clinical_drug__bcr_drug_uuid	46461aeb-bab0-45f1-a893-fcd00a28bbea
clinical_drug__bcr_patient_barcode	tcga-a7-a5zx
clinical_drug__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_drug__form_completion_date	2013-11-15
clinical_drug__pharmaceutical_therapy_drug_name	paclitaxel
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	174
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	132
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-a7-a5zx-f52721
clinical_follow_up__bcr_followup_uuid	4168828d-e26a-4495-896f-2164a95a9fc2
clinical_follow_up__bcr_patient_barcode	tcga-a7-a5zx
clinical_follow_up__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-12-6
clinical_follow_up__last_contact_days_to	336
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-a7-a5zx-o40913
clinical_omf__bcr_omf_uuid	89f74224-23eb-46bf-8e73-89db830723c0
clinical_omf__bcr_patient_barcode	tcga-a7-a5zx
clinical_omf__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_omf__days_to_other_malignancy_dx	46
clinical_omf__days_to_surgical_resection	46
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2013-3-6
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	invasive lobular carcinoma with lobular carcinoma in-situ
clinical_omf__other_malignancy_laterality	right
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	nx
clinical_omf__pathologic_T	t1b
clinical_omf__pathologic_stage	stage ia
clinical_omf__radiation_tx_indicator	no
clinical_omf__surgery_indicator	yes
clinical_omf__surgery_type	right breast  prophylactic mastectomy
clinical_omf__system_version	7th
clinical_patient__age_at_diagnosis	48
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n3a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiic
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-a7-a5zx
clinical_patient__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_patient__birth_days_to	-17683
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__first_surgical_procedure_other	bilateral skin sparing mastectomy and bilateral breast reconstruction with tissue expanders.
clinical_patient__form_completion_date	2013-5-13
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2012
clinical_patient__last_contact_days_to	132
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	24
clinical_patient__lymph_nodes_examined_he_count	21
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__new_tumor_event_dx_indicator	no
clinical_patient__patient_id	a5zx
clinical_patient__pharmaceutical_tx_adjuvant	yes
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__radiation_treatment_adjuvant	no
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	a7
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a7-a5zx
clinical_radiation__bcr_patient_uuid	ba80db4e-d899-4da4-ae49-5263d98e1530
clinical_radiation__bcr_radiation_barcode	tcga-a7-a5zx-r51335
clinical_radiation__bcr_radiation_uuid	0352da94-e095-4db4-96ee-242b04b52219
clinical_radiation__form_completion_date	2013-11-15
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	263
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	227
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	5040
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A7-A5ZX-01A-12D-A29N-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A7-A5ZX-01A-12D-A29N-09.bed.meta
manually_curated__id	tcga-a7-a5zx-01a-12d-a29n-09
manually_curated__md5sum	1cd11666eeaf87a972fd8d72940b4dbb
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	1e19a22f-97e3-4a9a-aa55-fb18dd6b674b
manually_curated__tumor_tag	brca
